Arkolith/Insider Trading/RAPP/Form 4

Bredt David

Chief Scientific OfficerRapport Therapeutics, Inc. (RAPP) · full profile →Form 4 · filed Oct 16, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$219K
Net Open-Market Flow
-$219K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 15, 2025Sell(S)1K$26.16$28K410K
Oct 15, 2025Sell(S)7K$25.73$191K411K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-241475) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML